Orders from 465 AED Free delivery from 965 AED Ready for pickup dead drop: collect in 5 min

Substances · Arylcyclohexylamines

3-MeO-PCE

C15H23NO CAS 1364933-83-4 Analytical reference material — not for human consumption
Preferred name
3-MeO-PCE
IUPAC name
N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine
Parent CAS number (reference)
1364933-83-4
Molecular formula
C15H23NO
Molecular weight
233.35 g/mol
InChIKey
OFGOOZLOGUNDFS-UHFFFAOYSA-N
PubChem
CID 57461569
Source
PubChem
Verified synonyms & catalog abbreviations
3-Methoxyeticyclidine Methoxieticyclidine 3MeOPCE 3-MeO PCE

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

3-MeO-PCE

Serotonergic High-Potency NMDA Antagonist Arylcyclohexylamine
Verified PubChem & CAS Identity C15H23NO · CAS 1364933-83-4 · CID 57461569
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 233.35 g/mol
Peer-Reviewed & Agency Citations 2 · verified sources

Receptor Telemetry & Mechanism of Action

NMDA Uncompetitive Channel Blockade Primary
SERT / DAT Monoamine Reuptake Tone Moderate

Combines potent NMDA blockade (Ki = 61 nM) with strong SERT binding (Ki = 115 nM), yielding warm, introspective dissociation.

Biotransformation & Active Metabolites

O-demethylation and N-deethylation.

Temporal Pharmacokinetics

Serotonergic High-Potency NMDA Antagonist — Warmer and more serotonergic-leaning than 3-MeO-PCP or O-PCE (common 10–16 mg), with strict contraindication against serotonergic drugs.

  1. Onset 40–90 min
  2. Peak Window 2–4 h
  3. Total Window 5–8 h
  4. Residual / Half-Life 6–16 h residual

Warmer and more serotonergic-leaning than 3-MeO-PCP or O-PCE (common 10–16 mg), with strict contraindication against serotonergic drugs.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
3–5 mg
Cognitive & Sensory

Subtle threshold receptor activity (Serotonergic High-Potency NMDA Antagonist).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
5–10 mg
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
10–16 mg
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
16–22 mg
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
25+ mg
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

Alcohol, Opioids (O-DSMT), Benzodiazepines, and GHB/GBL

Severe ataxia, unconsciousness, respiratory depression, and fatal vomiting aspiration.

MAOIs, MDMA, 4-MMC, 3-CMC, and Serotonin Releasers

SERT inhibition combined with monoamine releasers or MAOIs precipitates potentially fatal serotonin syndrome and hyperthermia.

Elevated Hazard — Avoid

Strong Stimulants (Cathinones, Cocaine, Amphetamines)

Compounds hypertension, tachycardia, manic disorientation, and psychotic episodes.

Caution / Receptor Attenuation

Cannabis & Psychedelics

Dramatically intensifies dissociation, confusion, and sensory immersion.

Structural Isomer & Sibling Comparison

Warmer and more serotonergic-leaning than 3-MeO-PCP or O-PCE (common 10–16 mg), with strict contraindication against serotonergic drugs.

Physicochemical Stability & Storage

Form: White to off-white crystalline powder or fine crystals. · Soluble in water, ethanol, and saline.

Chemically stable when kept dry, sealed, and protected from light at room temperature.

Cross-Tolerance & Dependence Profile

Slowly decaying NMDA cross-tolerance shared across all arylcyclohexylamines (halves in ~3–7 days, full baseline 2+ weeks). Chronic frequent exposure carries documented urological/bladder epithelial toxicity.

Comprehensive Analytical & Toxicological Monograph

3-MeO-PCE (N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine; CAS 1364933-83-4, PubChem CID 57461569) is a arylcyclohexylamine reference compound (C15H23NO, 233.35 g/mol) classified pharmacologically as a Serotonergic High-Potency NMDA Antagonist. Combines potent NMDA blockade (Ki = 61 nM) with strong SERT binding (Ki = 115 nM), yielding warm, introspective dissociation. O-demethylation and N-deethylation. In published observational and toxicological literature, threshold response is noted at 3–5 mg, light range at 5–10 mg, common reference range at 10–16 mg, strong intensity at 16–22 mg, and heavy/adverse territory at 25+ mg, with an onset of 40–90 min, peak window of 2–4 h, and total duration of 5–8 h (6–16 h residual). Warmer and more serotonergic-leaning than 3-MeO-PCP or O-PCE (common 10–16 mg), with strict contraindication against serotonergic drugs. Critical contraindications include Alcohol, Opioids (O-DSMT), Benzodiazepines, and GHB/GBL, MAOIs, MDMA, 4-MMC, 3-CMC, and Serotonin Releasers.

Chemical Architecture & Structural Profile

3-MeO-PCE (N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine) is a reference compound belonging to the Arylcyclohexylamines class, characterized by the molecular formula C15H23NO and a molar mass of 233.35 g/mol. The parent molecule is indexed under CAS registry number 1364933-83-4 and in the NCBI PubChem database as CID 57461569 (Standard InChIKey: OFGOOZLOGUNDFS-UHFFFAOYSA-N). This molecule shares its empirical formula (C15H23NO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (1364933-83-4), and spectroscopic profile.

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 3-MeO-PCE is indexed within the Arylcyclohexylamines structural group. Toxicological notes (PsychonautWiki): toxic threshold is unknown. Dependence liability (PsychonautWiki): highly addictive with a high potential for adverse side effects such as psychosis. Documented cross-tolerance class: dissociatives. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations

Documented Contraindications & Interactions

High-risk / Dangerous combinations